It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This study aims to understand the mechanistic basis underlying the response of Bifidobacterium to lactulose ingestion in guts of healthy Japanese subjects, with specific focus on a lactulose transporter. An in vitro assay using mutant strains of Bifidobacterium longum subsp. longum 105-A shows that a solute-binding protein with locus tag number BL105A_0502 (termed LT-SBP) is primarily involved in lactulose uptake. By quantifying faecal abundance of LT-SBP orthologues, which is defined by phylogenetic analysis, we find that subjects with 107 to 109 copies of the genes per gram of faeces before lactulose ingestion show a marked increase in Bifidobacterium after ingestion, suggesting the presence of thresholds between responders and non-responders to lactulose. These results help predict the prebiotics-responder and non-responder status and provide an insight into clinical interventions that test the efficacy of prebiotics.
Yoshida et al. investigate the role of an ABC transporter (LT-SBP) in lactulose metabolism and its putative role in enriching the gut microbiota with bifidobacteria that encode this transporter. Their results might help in predicting prebiotics-responder and nonresponder status, helping the clinical interventions testing the efficacy of prebiotics.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Morinaga Milk Industry Co., Ltd., Next Generation Science Institute, RD Division, Zama, Japan (GRID:grid.419972.0) (ISNI:0000 0000 8801 3092)
2 Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Nonoichi, Japan (GRID:grid.410789.3) (ISNI:0000 0004 0642 295X); Kindai University, Biology-Oriented Science and Technology, Kinokawa, Japan (GRID:grid.258622.9) (ISNI:0000 0004 1936 9967)
3 Morinaga Milk Industry Co., Ltd, Food Ingredients and Technology Institute, RD Division, Zama, Japan (GRID:grid.419972.0) (ISNI:0000 0000 8801 3092)
4 Kyoto University, Graduate School of Biostudies, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
5 Kyoto University, Graduate School of Biostudies, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033); Ishikawa Prefectural University, Faculty of Bioresources and Environmental Sciences, Nonoichi, Japan (GRID:grid.410789.3) (ISNI:0000 0004 0642 295X)
6 Kindai University, Biology-Oriented Science and Technology, Kinokawa, Japan (GRID:grid.258622.9) (ISNI:0000 0004 1936 9967); Ishikawa Prefectural University, Faculty of Bioresources and Environmental Sciences, Nonoichi, Japan (GRID:grid.410789.3) (ISNI:0000 0004 0642 295X)
7 Showa Women’s University, Life Science for Living System, Graduate School, Tokyo, Japan (GRID:grid.412583.9) (ISNI:0000 0001 2175 6139)